The 5-HT1A Receptor and the Stimulus Effects of LSD in the Rat

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2005 Jul 19

PMID 16025319

Citations 24

Authors

C J Reissig

J R Eckler

R A Rabin

J C Winter

Affiliations

Soon will be listed here.

Abstract

Rationale: It has been suggested that the 5-HT1A receptor plays a significant modulatory role in the stimulus effects of the indoleamine hallucinogen lysergic acid diethylamide (LSD).

Objective: The present study sought to characterize the effects of several compounds with known affinity for the 5-HT1A receptor on the discriminative stimulus effects of LSD.

Methods: Twelve male Fischer 344 rats were trained in a two-lever, fixed-ratio (FR) 10, and food-reinforced task with LSD (0.1 mg/kg, i.p.; 15-min pretreatment) as a discriminative stimulus. Combination and substitution tests with the 5-HT(1A) agonists, 8-OH-DPAT, buspirone, gepirone, and ipsapirone, with LSD-induced stimulus control were then performed. The effects of these 5-HT1A ligands were also tested in the presence of the selective 5-HT1A receptor antagonist, WAY-100,635 (0.3 mg/kg, s.c.; 30-min pretreatment).

Results: In combination tests, stimulus control by LSD was increased by all 5-HT1A receptor ligands with agonist properties. Similarly, in tests of antagonism, the increase in drug-appropriate responding caused by stimulation of the 5-HT1A receptor was abolished by administration of WAY-100,635.

Conclusion: These data, obtained using a drug discrimination model of the hallucinogenic effects of LSD, provide support for the hypothesis that the 5-HT1A receptor has a significant modulatory role in the stimulus effects of LSD.

Citing Articles

A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to....

Hibicke M, Kramer H, Nichols C Psychedelic Med (New Rochelle). 2025; 1(1):54-67.

PMID: 40047006 PMC: 11661400. DOI: 10.1089/psymed.2022.0012.

1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents - A Review.

Glennon R, Dukat M ACS Pharmacol Transl Sci. 2024; 7(6):1722-1745.

PMID: 38898956 PMC: 11184610. DOI: 10.1021/acsptsci.4c00157.

Serotonin 2C receptors are also important in head-twitch responses in male mice.

Custodio R, Ortiz D, Lee H, Sayson L, Kim M, Lee Y Psychopharmacology (Berl). 2023; .

PMID: 37882810 DOI: 10.1007/s00213-023-06482-9.

Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence.

Inserra A, Piot A, De Gregorio D, Gobbi G CNS Drugs. 2023; 37(9):733-754.

PMID: 37603260 DOI: 10.1007/s40263-023-01008-5.

The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.

Mastinu A, Anyanwu M, Carone M, Abate G, Bonini S, Peron G Int J Mol Sci. 2023; 24(2).

PMID: 36674849 PMC: 9865175. DOI: 10.3390/ijms24021329.

References

Egan C, Herrick-Davis K, Miller K, Glennon R, Teitler M . Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors. Psychopharmacology (Berl). 1998; 136(4):409-14. DOI: 10.1007/s002130050585. View

Schreiber R, Brocco M, Millan M . Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. Eur J Pharmacol. 1994; 264(1):99-102. DOI: 10.1016/0014-2999(94)90643-2. View

Hoyer D, Hannon J, Martin G . Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav. 2002; 71(4):533-54. DOI: 10.1016/s0091-3057(01)00746-8. View

Gingrich J, Hen R . Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl). 2001; 155(1):1-10. DOI: 10.1007/s002130000573. View

Hensler J . Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci. 2003; 72(15):1665-82. DOI: 10.1016/s0024-3205(02)02482-7. View

Sarnyai Z, Sibille E, Pavlides C, Fenster R, McEwen B, Toth M . Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc Natl Acad Sci U S A. 2000; 97(26):14731-6. PMC: 18987. DOI: 10.1073/pnas.97.26.14731. View

Geyer M . Evidence for a functional interaction between 5-HT1A and 5-HT2 receptors in rats. Psychopharmacology (Berl). 1998; 140(1):69-74. DOI: 10.1007/s002130050740. View

Meltzer H . The role of serotonin in antipsychotic drug action. Neuropsychopharmacology. 1999; 21(2 Suppl):106S-115S. DOI: 10.1016/S0893-133X(99)00046-9. View

Penington N, Fox A . Effects of LSD on Ca++ currents in central 5-HT-containing neurons: 5-HT1A receptors may play a role in hallucinogenesis. J Pharmacol Exp Ther. 1994; 269(3):1160-5. View

10.

Arnt J, Hyttel J . Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI. Eur J Pharmacol. 1989; 161(1):45-51. DOI: 10.1016/0014-2999(89)90178-7. View

11.

Glennon R, Titeler M, McKenney J . Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 1984; 35(25):2505-11. DOI: 10.1016/0024-3205(84)90436-3. View

12.

Winter J, Rabin R . Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus. Pharmacol Biochem Behav. 1988; 30(3):617-24. DOI: 10.1016/0091-3057(88)90074-3. View

13.

Winter J, Fiorella D, Helsley S, Rabin R . Partial generalization of (-)DOM to fluvoxamine in the rat: implications for SSRI-induced mania and psychosis. Int J Neuropsychopharmacol. 2001; 2(3):165-172. DOI: 10.1017/S1461145799001510. View

14.

Hamon M, Bourgoin S, Gozlan H, Hall M, Goetz C, Artaud F . Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. Eur J Pharmacol. 1984; 100(3-4):263-76. DOI: 10.1016/0014-2999(84)90002-5. View

15.

Cunningham K, Callahan P, Appel J . Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics. Eur J Pharmacol. 1987; 138(1):29-36. DOI: 10.1016/0014-2999(87)90333-5. View

16.

Fiorella D, Rabin R, Winter J . The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis. Psychopharmacology (Berl). 1995; 121(3):347-56. DOI: 10.1007/BF02246074. View

17.

Doat M, Rabin R, Winter J . Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD. Pharmacol Biochem Behav. 2003; 74(3):713-21. DOI: 10.1016/s0091-3057(02)01074-2. View

18.

Marona-Lewicka D, Nichols D . Aripiprazole (OPC-14597) fully substitutes for the 5-HT1A receptor agonist LY293284 in the drug discrimination assay in rats. Psychopharmacology (Berl). 2003; 172(4):415-21. DOI: 10.1007/s00213-003-1677-6. View

19.

Arvanov V, Liang X, Russo A, Wang R . LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex. Eur J Neurosci. 1999; 11(9):3064-72. DOI: 10.1046/j.1460-9568.1999.00726.x. View

20.

Aghajanian G, Hailgler H . Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors. Psychopharmacol Commun. 1975; 1(6):619-29. View